spacer
home > ict > winter 2019 > animal models to study infectious pathogens
PUBLICATIONS
International Clinical Trials

Animal Models to Study Infectious Pathogens

Until recently, several issues prevented the use of cotton rats (Sigmodon hispidus) as an experimental model on a widespread level. They lacked inbreeding, they were not readily commercially available, and reagents specific to this species had yet to be developed. Additionally, cotton rats are notoriously hard models to work with. Although cotton rats are not normally aggressive, they dislike being handled, can move very rapidly, and jump well. Significant advances have now been made to alleviate these issues. A variety of immunological methods have been established for the cotton rat so that immunological responses after infection or vaccination can be evaluated. Also, a wide variety of chemokine and cytokine genes have been cloned and enzyme-linked immunosorbent assay and other antibody-based systems are readily available. Some strategies can overcome the challenges of working with cotton rats, and their necessity to vaccine development ultimately makes them more than worth the trouble.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Carmen Sweeney PhD is the Scientific Director of in vivo/ex vivo testing services at Charles River’s site, Ballina, Ireland. Carmen has over 20 years’ experience in the industry, having held a number of positions at Charles River, from Study Director, Manager of Methods Development, to her current role. Carmen received her PhD in biological and biomedical sciences and toxicology MSc from the University of Ulster, UK.
spacer
Carmen Sweeney PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

IATA CEIV Pharma certificate of Turkish Cargo renewed

Turkish Cargo, the air cargo brand flying to the most countries around the world, extended the validity period of its IATA CEIV (Center of Excellence for Independent Validators) Pharma certificate to 2022, proving its success in all processes throughout the air transportation of medicinal products.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 
Industry Events

ESMO Targeted Anticancer Therapies Congress 2020

2-4 March 2020, Paris, France

A unique and international mix of experts, researchers and decision makers both from academia and industry across the globe, will convene in Paris for a three-day Congress aiming at exchanging knowledge, experience and research innovations in cancer. TAT 2020 will focus, among others, on novel strategies in immuno-oncology, personalised medicine and molecular tumour boards, preclinical studies to identify effective combination therapies, use of microbiome, tumour agnostic trials, ADC technology, oncolytics, multispecific biological constructs and targeting cytokines. Participating in TAT 2020 will offer you the possibility to take part in interdisciplinary discussions inspiring new ideas and new collaborations.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement